Validation of Histologic and Noninvasive Measures of Fibrosis as Surrogate Endpoints of Disease Progression in Patients with Primary Sclerosing Cholangitis

Conference Reports for NATAP

The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria


Validation of Histologic and Noninvasive Measures of Fibrosis as Surrogate Endpoints of Disease Progression in Patients with Primary Sclerosing Cholangitis

	Reported by Jules Levin EASL 2019 Vienna April 10-14